Skip to Main Content

Author Details

Franz Recker
PolyClinic St. Moritz/Scuol
1986
82
24
PMIDPaper TitleJournal TitlePublished Year
37088597Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer.Eur Urol2023
34350895Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies.Urol Int2022
31865534Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau).World J Urol2020
30928162Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?Eur Urol2019
30824296A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.Eur Urol2019
29023685Summary statement on screening for prostate cancer in Europe.Int J Cancer2018
28376164Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst2017
26332304A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).BJU Int2016
24794075A "PSA pyramid" for men with initial prostate-specific antigen ⿤3 ng/ml: a plea for individualized prostate cancer screening.Eur Urol2015
25633871Differences among men on active surveillance for very low-risk prostate cancer detected through population-based versus opportunistic prostate-specific antigen-screening.Urol Int2015
25565393Is further screening of men with baseline PSA⿿<⿿1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau).Int J Cancer2015
25532573Prostate cancer screening: and yet it moves!Asian J Androl2015
25358675Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau).World J Urol2015
23712424[PSA screening 2013: background and perspectives].Urologe A2014
25505238Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.J Natl Cancer Inst2014
25108889Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.Lancet2014
24820259A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center.World J Urol2014
24144432Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.Eur Urol2014
22093744Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort.BJU Int2012
22704366Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).Eur Urol2012
22770614Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners.Urology2012
22874102Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.Epigenetics2012
22258377[U.S. Preventive Services Task Force recommendation or "throwing out the baby with the bath water"].Urologe A2012
22285762Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.Eur Urol2012
22417251Prostate-cancer mortality at 11 years of follow-up.N Engl J Med2012
20127638[In depth analysis of 2 studies of prostate cancer screening--what makes sense?].Praxis (Bern 1994)2010
20967984[Standardization of the laboratory test for PSA].Urologiia2010
19297566Screening and prostate-cancer mortality in a randomized European study.N Engl J Med2009
19660851Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).Eur Urol2009
18560799[Status of care for prostate cancer in 2008].Urologe A2008
18791963[Selective application of tumor markers PSA].Ther Umsch2008
16697520A (-5, -7) proPSA based artificial neural network to detect prostate cancer.Eur Urol2006
16514966[Prostate specific antigen in individual cancer checkups and in therapeutic treatment].Ther Umsch2006
15253159[PSA-screening for prostate cancer--yes or no?].Ther Umsch2004
15592949Prostate cancer screening: results of a prospective trial in Canton Aargau, Switzerland.Swiss Med Wkly2004
14501719A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations.J Urol2003
14983954Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland.BJU Int2003
14983946The story of the European Randomized Study of Screening for Prostate Cancer.BJU Int2003
11490232Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.J Urol2001
11277057Retroperitoneal laparoscopic nephropexy.Urol Clin North Am2001
11232548A severe complication of retroperitoneoscopic nephrectomy.J Urol2001
10736487Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.Urology2000
10667080[Prostatic carcinoma. Screening--when and what?].Ther Umsch2000
10475354Intravesical therapy with pertussis toxin before radical cystectomy in patients with bladder cancer: a Phase I study.Urology1999
9730444In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.Urology1998
9874461The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.Cancer1998
9598623Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels.Br J Urol1998
9598536Development of testicular seminoma after previous negative biopsy for testicular intraepithelial neoplasia.J Urol1998
9628596Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association.J Urol1998
9743696Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.Eur Urol1998
  • 1 - 50 of 82

Recommended Authors

Edward Rowe
Bristol Urological Institute, Southmead Hospital
Career Start Year 2004
Number of shared co-authors 3
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 4
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Michael Stoeckle
Saarland University
Career Start Year 2000
Number of shared co-authors 0
J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 0
David Nicol
The Royal Marsden Hospital
Career Start Year 1993
Number of shared co-authors 4
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 2
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 2
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 3
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Career Start Year 1989
Number of shared co-authors 4
Philip Cornford
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 3
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 7
Damien Bolton
University of Melbourne
Career Start Year 1988
Number of shared co-authors 7
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 8
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 6
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 10
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 10
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 3
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 8
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 5
Yves Chr??tien
European Hospital Georges Pompidou, University of Paris Descartes
Career Start Year 1982
Number of shared co-authors 0
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 7
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 11
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 5
Eric J Bergstralh
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 1
Keong Tatt Foo
Rutgers Cancer Institute of New Jersey
Career Start Year 1975
Number of shared co-authors 0
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 12
Anthony J Costello
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 7
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 6
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year 1956
Number of shared co-authors 4

Collaborators

Maciej Kwiatkowski
University of Basel, Academic Hospital Braunschweig
Co-authored papers 41
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 11
Marco Randazzo
Winterthur Cantonal Hospital
Co-authored papers 10
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 6
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Co-authored papers 2
Ekaterina Olkhov-Mitsel
University of Toronto
Co-authored papers 2
Laurent Briollais
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Co-authored papers 2
Bharati Bapat
Mt Sinai Hospital
Co-authored papers 2
Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 2
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 2
Neil E Fleshner
University of Toronto
Co-authored papers 2
Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 2
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 1
Tristan Juvet
Lions Gate Hospital
Co-authored papers 1
Antoninus Soosaipillai
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Robert G Bristow
University of Toronto
Co-authored papers 1
Karen Chadwick
University Health Network, University of Toronto
Co-authored papers 1
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 1
Matt Friedlander
Ontario Institute for Cancer Research
Co-authored papers 1
Angelika Hammerer-Lercher
Co-authored papers 1
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 1
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 1
Hong Li
Qingdao Hospital of Traditional Chinese Medicine, Qingdao Haici Hospital
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Christine Massey
Princess Margaret Cancer Centre
Co-authored papers 1
Ioannis Prassas
Mount Sinai Hospital
Co-authored papers 1
Sally Hanna
Mount Sinai Hospital
Co-authored papers 1
Geoffrey A M Hunter
Ontario Institute for Cancer Research
Co-authored papers 1
Emilie Lalonde
University of Pennsylvania
Co-authored papers 1
Thorsten Schlomm
Charite - University Hospital Berlin
Co-authored papers 1
Release 1.2